Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cahill

Showing results (261-270 of 425) with videos related to

Pageof 43
Sort By:
International Journal of Cancer|August 13, 2017
Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma modelsShinichi Esaki, Fares Nigim, Esther Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2024
Mutant IDH Modulates Suppressive Myeloid Populations in Malignant GliomaEric P Grewal, Leland G K Richardson, Jing Sun, et al.
Annals of Diagnostic Pathology|March 27, 2012
Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric gliomaAditya Raghunathan, Adriana Olar, Hannes Vogel, et al.
Journal of Neuro-Oncology|June 10, 2026
Comparison between molecular and histological IDH-wild-type glioblastoma and extensive subgroup analysis of IDH-wild-type astrocytic tumors without genomic glioblastoma-defining alterationsAnna M Seifert, Sven Richter, André Sagerer, et al.
Neuro-Oncology|December 24, 2021
ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant gliomaChengchen Hu, Kimberly Wang, Ceylan Damon, et al.
Targeted Oncology|July 14, 2019
A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade MeningiomaFares Nigim, Juri Kiyokawa, Alessandra Gurtner, et al.
Neurologia Medico-Chirurgica|May 10, 2021
Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot MutationsShingo Fujio, Tareq A Juratli, Tomoko Takajo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
Myc-Driven Glycolysis Is a Therapeutic Target in GlioblastomaKensuke Tateishi, A John Iafrate, Quan Ho, et al.
Neuro-Oncology|March 9, 2016
A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virusFares Nigim, Shin-Ichi Esaki, Michael Hood, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 2, 2019
Factors that modify the risk of intraoperative seizures triggered by electrical stimulation during supratentorial functional mappingJennifer Dineen, Douglas C Maus, Iryna Muzyka, et al.
Pageof 43

Showing results (261-270 of 425) with videos related to

Sort By:
Pageof 43
International Journal of Cancer|August 13, 2017
Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma modelsShinichi Esaki, Fares Nigim, Esther Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2024
Mutant IDH Modulates Suppressive Myeloid Populations in Malignant GliomaEric P Grewal, Leland G K Richardson, Jing Sun, et al.
Annals of Diagnostic Pathology|March 27, 2012
Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric gliomaAditya Raghunathan, Adriana Olar, Hannes Vogel, et al.
Journal of Neuro-Oncology|June 10, 2026
Comparison between molecular and histological IDH-wild-type glioblastoma and extensive subgroup analysis of IDH-wild-type astrocytic tumors without genomic glioblastoma-defining alterationsAnna M Seifert, Sven Richter, André Sagerer, et al.
Neuro-Oncology|December 24, 2021
ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant gliomaChengchen Hu, Kimberly Wang, Ceylan Damon, et al.
Targeted Oncology|July 14, 2019
A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade MeningiomaFares Nigim, Juri Kiyokawa, Alessandra Gurtner, et al.
Neurologia Medico-Chirurgica|May 10, 2021
Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot MutationsShingo Fujio, Tareq A Juratli, Tomoko Takajo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
Myc-Driven Glycolysis Is a Therapeutic Target in GlioblastomaKensuke Tateishi, A John Iafrate, Quan Ho, et al.
Neuro-Oncology|March 9, 2016
A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virusFares Nigim, Shin-Ichi Esaki, Michael Hood, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 2, 2019
Factors that modify the risk of intraoperative seizures triggered by electrical stimulation during supratentorial functional mappingJennifer Dineen, Douglas C Maus, Iryna Muzyka, et al.
Pageof 43